• Search

  • Post Date

  • Categories

  • Contributors

Archives

Hepatitis C Boot Camp 1: Pathogenesis, Epidemiology, and Treatment Guidelines

By Jamie Morano, MD

January 25th, 2019
Dr. Jamie Morano reviews updated information regarding the current epidemiology, prevalence, pre-treatment assessment, and therapeutic options for the management of this common viral pathogen.  She begins by discussing current worldwide epidemiology.  She breaks down U.S. trends both regionally and state by state. She elaborates on the significance of specific genotypes in hepatitis treatment and in disease complications. Testing guidelines are also reviewed. Next, Dr. Morano reviews current antiviral therapies and breaks them down by agent and co-formulation. Lastly, she discusses pretreatment options for patients who fail initial therapy.

Medical and Diagnostic Mycobacteriology of Importance to the Clinician and Pathologist

By Ramon Sandin, MD, MS, FCAP

January 23rd, 2019

Dr. Sandin provides a general overview of identification techniques for Mycobacterial organisms. He discusses and outlines classification systems for the Mycobacteria that are human pathogens. He then discusses laboratory stains that are useful in identifying Mycobacteria and reviews other diagnostic methods which have become essential to Mycobacterial species identification, including the various nucleic amplification-based methods. Various pathology pearls of Mycobacterial identification are also mentioned. Lastly, he discusses two clinical cases involving acid fast organisms.

Dates in Infectious Diseases: Ancient History Edition

By Richard L. Oehler, MD

January 10th, 2019

Dr. Oehler conducts a lively quiz session regarding infectious diseases historical figures and events dating from 600 BC to 1900. In this fast paced and humorous podcast, listeners are exposed to the accomplishments of infectious disease titans such as Hippocrates, Anton Van Leewenhoek, Ignaz Semmelweis, and John Snow. After listening to this podcast, participants will have a much broader sense of the legacy of infectious diseases history as well as some other fascinating trivia that will entertain and amaze!

To enjoy the companion lecture to this one regarding 20th Century ID events, please watch this presentation:

https://idpodcasts.net/podcasts/dates-in-id-20th-century-edition/

Understanding Military MSMs: STI, PrEP, and ID Care in your Medical Practice

By Jamie Morano, MD

November 21st, 2018

Dr. Jamie Morano reviews sexually transmitted infections among MSMs (men who have sex with men). She discusses current sexually transmitted infection screening, testing, and treatment guidelines for the group. The use of preexposure prophylaxis for MSMs is also introduced, and includes information on eligibility and an implementation strategy for patients. Lastly, Dr. Morano touches upon HIV screening and rapid treatment approaches to care.

Meeting the Resistance Movement, Up Close and Personal: Understanding HIV Resistance

By Jamie Morano, MD

November 5th, 2018

Dr. Jamie Morano reviews HIV infection. She starts out by presenting up to date statistics about the current epidemiology of HIV infection across the US and Florida. She then goes on to discuss the HIV life cycle, and how various antiretroviral treatments appear to interact with the virus at different points of the viral reproductive process. HIV resistance mechanisms are also addressed. Lastly, she shares her recommendations on strategies useful to selecting an ideal antiretroviral regimen for an HIV positive patient.

Invasive Fungal Infections in the Immunosuppressed

By Aliyah Baluch, MD, Msc

October 19th, 2018

Dr. Baluch reviews the topic of invasive fungal infections (IFIs) in individuals who undergo hematopoietic stem cell transplantation (HCST). The author begins by reviewing risk factors for IFIs. She then discusses what constitutes an IFI. She differentiates infections caused by yeasts versus those due to molds, and discusses the assessment and management of invasive candida disease. Next, Dr. Baluch discusses non candida molds, including aspergillus, fusarium, and Mucor as well as atypical pathogens such as Pneumocystis. She closes with a discussion of antifungal therapy and what constitutes the ideal fungal agent.

Antimicrobial Drug Interactions

By Tiffany Ward

October 9th, 2018

Dr. Ward reviews basic concepts about antimicrobial drug interactions. She begins by discussing the basic classification scheme, and then moves on to discuss several commonly recognized adverse drug interactions, as well as some that are commonly forgotten. She also reviews the topic of QT drug prolongation, the interaction between daptomycin and statins, as well as the most relevant azole interactions. She reviews serotonergic interactions, especially with linezolid. Lastly, she reviews the interaction between valproic acid and carbapenems. And the best reference sources for reviewing adverse drug interactions with antimicrobials are also discussed.

Viral Hemorrhagic Fevers

By Awais Chugtai, MD

August 30th, 2018

Dr. Chugtai reviews the family of Viral Hemorrhagic Fevers. He starts out by discussing transmission factors and major common symptoms for the class of disorders. He then covers the Bunyaviridae, including Hantavirus Pulmonary Syndrome and Rift Valley Fever. Dr. Chugtai then mentions the hemorrhagic fevers, including Ebola and Marburg viruses. Other hemorrhagic fevers dicussed includes Nipah virus disease and Hendra virus disease. Lastly, he discusses the flaviviruses, including Tick-borne encephalitis (TBE).

Infections of Intravascular Catheters

By Richard L. Oehler, MD

August 17th, 2018

In this updated talk, Dr. Oehler discusses the assessment and management of infections of central catheters. Dr. Oehler begins his talk by covering the epidemiology of central line infections, including the most common organisms involved, and covers the different types of intravascular devices. He then discusses the mechanisms by which central line associated bloodstream infections (CLABSI’s) occur, differentiating hematogenous, hub-related, entry site, and infusate-related etiologies. He also covers infection risk factors, the diagnostic workup, and under what circumstances device removal is necessary. Infection management in the context of specific pathogens is also addressed. Furthermore, Dr. Oehler discusses the concept of antibiotic lock therapy and how it can be an adjunctive management strategy. Lastly, Dr. Oehler differentiates between insertion site and exit site infections where they relate to tunneled catheters and offers a summary of the 5 most effective approaches to reducing CLABSIs in the hospital setting.

Infections in Pregnancy

By Natan Kraitman, MD

August 3rd, 2018

Dr. Kraitman reviews the management and treatment of infections occurring in the pregnant female. He initially reviews medication pregnancy risk categories, and then through interactive case review, goes over several examples where antimicrobial agents are used that are contraindicated in pregnancy. He reviews interactions relevant to HIV/AIDS, AIDS associated opportunistic infections, Tuberculosis, Malaria, CMV, Syphilis, and Listeria. He closes by providing information on useful reference resources for managing infections in pregnancy.